HomeEverythingEducation
Equities & FundsCrypto & Digital AssetsAI & TechnologyBusiness & CorporateUS Politics & PolicyGeopolitics & Global RiskMacro, Rates & FXCommodities & EnergyEuropean Politics & MarketsAsia-PacificReal Estate & Property
Story archiveAll categories
← All Stories

Kirin Holdings accelerates Asia-Pacific health science expansion

Created at 10 Jul · 2:30 AM1 source↑ Market-relevant
IN SHORT

Kirin Holdings is accelerating the expansion of its health science business in the Asia-Pacific region, aiming to become a major player. The company will establish Kirin Health Science International Pty Ltd to oversee its overseas B2C health science operations.

✉Newsletter

PiQ Daily

Pick your topics. Get only what matters, on your cadence.

Key Numbers

100%Kirin Holdings ownership of KHSI

Who's Involved

Kirin Holdings
Japanese beverage maker expanding health science business
Kirin Health Science International Pty Ltd
New subsidiary to oversee overseas B2C health science operations
Alastair Symington
President of Kirin Health Science International and CEO of Blackmores
Blackmores
Group company whose assets will be integrated into KHSI
FANCL
Group company whose assets will be integrated into KHSI
Kyowa Hakko Bio
Group company whose assets will be integrated into KHSI
Koiwai Dairy Products
Group company whose assets will be integrated into KHSI
Kirin Holdings accelerates Asia-Pacific health science expansion

↳ Why This Matters

Kirin Holdings' strategic expansion into the health science sector in Asia-Pacific signifies a significant push to capitalize on growing global health demands and diversify its business beyond traditional beverages. The establishment of KHSI aims to create a unified and competitive international presence, integrating various group assets to offer comprehensive health solutions.

Key facts

  • Kirin Holdings is accelerating the Asia-Pacific expansion of its health science business.
  • The company aims to become a leading regional player in the health science sector.
  • A new entity, Kirin Health Science International Pty Ltd (KHSI), will be established on April 1, 2026.
  • KHSI will manage the business-to-consumer (B2C) segment of Kirin's health science operations outside of Japan.
  • The new company will consolidate brands, ingredients, and expertise from group companies including Blackmores and FANCL.
  • Kirin's strategy involves offering both 'internal' solutions (supplements, food, beverages) and 'external' solutions (skincare, information, services).

Japanese beverage maker Kirin Holdings is accelerating the expansion of its health science business across the Asia-Pacific region, with the goal of becoming a dominant player in the sector. To achieve this, the company will establish a new subsidiary, Kirin Health Science International Pty Ltd (KHSI), effective April 1, 2026.

KHSI, headquartered in Sydney, Australia, will be wholly owned by Kirin Holdings and will be responsible for managing the business-to-consumer (B2C) segment of the company's Health Science Domain outside of Japan. This strategic move aims to unify business activities that were previously managed independently across different regions, thereby enhancing operational efficiency, consistency, and competitiveness under a single global brand strategy and standardized business processes.

The new entity will integrate the brands, ingredients, technological assets, and expertise of Kirin's group companies, including established names like Blackmores, FANCL, Kyowa Hakko Bio, and Koiwai Dairy Products. Kirin's unique approach focuses on supporting both 'internal methods,' such as supplements, foods, and beverages, and 'external solutions,' encompassing skincare, information, services, and devices. Through this integrated strategy, KHSI intends to build foundational health, address individual health needs, and improve overall consumer well-being within the diverse lifestyles of consumers, primarily in the Asia Pacific region.

Frequently asked questions

The primary goal is to accelerate the expansion of Kirin's B2C health science business in the Asia-Pacific region and become one of the largest players in the sector.

KHSI will integrate brands, ingredients, technological assets, and expertise from group companies such as Blackmores, FANCL, Kyowa Hakko Bio, and Koiwai Dairy Products.

The new company will be based in Sydney, Australia.

Kirin's approach supports both 'internal methods' (supplements, foods, beverages) and 'external solutions' (skincare, information, services, devices) to promote foundational health and well-being.

What Happens Next

01Kirin Health Science International Pty Ltd to commence operations on April 1, 2026.

Get the newsletter.

Pick the topics you actually care about. We'll email when there's news worth your time, on the cadence you choose. Cancel any time from your account.

Cadence

How It Developed

Kirin Holdings announced plans to accelerate the Asia-Pacific expansion of its health science business.
The company aims to become one of the largest health science companies in the region.
Kirin Holdings will establish Kirin Health Science International Pty Ltd (KHSI) on April 1, 2026.
KHSI will oversee the B2C segment of Kirin's Health Science Domain outside Japan.
The new company will unify previously independently managed overseas business activities under a single global brand strategy.
KHSI will integrate brands, ingredients, technological assets, and expertise from group companies like Blackmores, FANCL, Kyowa Hakko Bio, and Koiwai Dairy Products.
The company will focus on delivering value tailored to diverse consumer lifestyles, particularly in the Asia Pacific region.

Sources

T1
Japan's Kirin bets on Asian expansion to grow health science businessNikkei Asia
T2
Kirin's Yoshimura on Health Science Business Strategybloomberg.com
T2
Kirin Establishes Kirin Health Science International Pty Ltd to ...kirinholdings.com
T2
Kirin Health Science International Pty Ltd Established in Australialinkedin.com

Related Stories

Vinci Airports expects slower traffic growth, remains bullish on Mexico
9 Jul · 8:28 PM
Nike and Adidas Vie for Soccer Dominance at World Cup
9 Jul · 9:11 AM
Qiagen Draws Early Takeover Interest From EQT, Advent & KKR
9 Jul · 3:07 PM
ANA's domestic fare revamp brings it closer to a budget airline
9 Jul · 4:51 PM
Hong Kong IVF clinic parent apologizes for embryo mix-up
9 Jul · 12:50 PM